Search research articles
Contact Us
Filters
Showing results (401-410 of 464) with videos related to
Page
of 47
Sort By:
Environmental and Molecular Mutagenesis
|
October 10, 2013
Bioassay-directed fractionation and sub-fractionation for mutagenicity and chemical analysis of diesel exhaust particles
Esra Mutlu, Sarah H Warren, Peggy P Matthews, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1994
Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group
I A Cooper, M M Wolf, T I Robertson, et al.
Cancer Research
|
March 15, 1994
Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase
A J Bitonti, J A Dumont, T L Bush, et al.
International Journal of Radiation Biology
|
June 24, 2011
Physically-based biodosimetry using in vivo EPR of teeth in patients undergoing total body irradiation
Benjamin B Williams, Ruhong Dong, Roberto J Nicolalde, et al.
Radiation Measurements
|
October 4, 2011
A Deployable In Vivo EPR Tooth Dosimeter for Triage After a Radiation Event Involving Large Populations
Benjamin B Williams, Ruhong Dong, Ann Barry Flood, et al.
Clinical and Translational Science
|
August 31, 2021
Safety, tolerability, and pharmacokinetics of single- and multiple-dose administration of islatravir (MK-8591) in adults without HIV
Randolph P Matthews, Wendy Ankrom, Evan Friedman, et al.
Nature Medicine
|
October 5, 2021
Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial
Randolph P Matthews, Munjal Patel, Stephanie E Barrett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 1998
Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparison
G C Toner, J D Shapiro, C R Laidlaw, et al.
Clinical Radiology
|
December 13, 2021
Parenchymal involvement on CT pulmonary angiography in SARS-CoV-2 Alpha variant infection and correlation of COVID-19 CT severity score with clinical disease severity and short-term prognosis in a UK cohort
M T Tsakok, R A Watson, S F Lumley, et al.
Clinical and Translational Science
|
September 15, 2025
Safety and Pharmacokinetics of MK-8527 in Adults Without HIV
Gillian Gillespie, Russ P Carstens, Xiaowei Zang, et al.
Page
of 47
Search research articles
Search
Showing results (401-410 of 464) with videos related to
Sort By:
Page
of 47
Environmental and Molecular Mutagenesis
|
October 10, 2013
Bioassay-directed fractionation and sub-fractionation for mutagenicity and chemical analysis of diesel exhaust particles
Esra Mutlu, Sarah H Warren, Peggy P Matthews, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1994
Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group
I A Cooper, M M Wolf, T I Robertson, et al.
Cancer Research
|
March 15, 1994
Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase
A J Bitonti, J A Dumont, T L Bush, et al.
International Journal of Radiation Biology
|
June 24, 2011
Physically-based biodosimetry using in vivo EPR of teeth in patients undergoing total body irradiation
Benjamin B Williams, Ruhong Dong, Roberto J Nicolalde, et al.
Radiation Measurements
|
October 4, 2011
A Deployable In Vivo EPR Tooth Dosimeter for Triage After a Radiation Event Involving Large Populations
Benjamin B Williams, Ruhong Dong, Ann Barry Flood, et al.
Clinical and Translational Science
|
August 31, 2021
Safety, tolerability, and pharmacokinetics of single- and multiple-dose administration of islatravir (MK-8591) in adults without HIV
Randolph P Matthews, Wendy Ankrom, Evan Friedman, et al.
Nature Medicine
|
October 5, 2021
Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial
Randolph P Matthews, Munjal Patel, Stephanie E Barrett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 1998
Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparison
G C Toner, J D Shapiro, C R Laidlaw, et al.
Clinical Radiology
|
December 13, 2021
Parenchymal involvement on CT pulmonary angiography in SARS-CoV-2 Alpha variant infection and correlation of COVID-19 CT severity score with clinical disease severity and short-term prognosis in a UK cohort
M T Tsakok, R A Watson, S F Lumley, et al.
Clinical and Translational Science
|
September 15, 2025
Safety and Pharmacokinetics of MK-8527 in Adults Without HIV
Gillian Gillespie, Russ P Carstens, Xiaowei Zang, et al.
Page
of 47